| scholarly article | Q13442814 |
| P50 | author | Zbyszek Otwinowski | Q9388794 |
| Dominika Borek | Q47451345 | ||
| Gaya K. Amarasinghe | Q52360446 | ||
| Christopher F Basler | Q54188848 | ||
| Daisy W Leung | Q88424073 | ||
| Megan C Edwards | Q95645917 | ||
| Parameshwaran Ramanan | Q115627243 | ||
| Ariel C Endlich-Frazier | Q117254613 | ||
| Reed S Shabman | Q37374407 | ||
| P2093 | author name string | Gai Liu | |
| Juyoung Huh | |||
| P2860 | cites work | DRBP76 associates with Ebola virus VP35 and suppresses viral polymerase function | Q24292964 |
| Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus | Q24310706 | ||
| Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. | Q38287391 | ||
| Sequence-based human leukocyte antigen-B typing of patients infected with Ebola virus in Uganda in 2000: identification of alleles associated with fatal and nonfatal disease outcomes | Q38877091 | ||
| Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function | Q39671255 | ||
| Homo-oligomerization of Marburgvirus VP35 is essential for its function in replication and transcription | Q39796970 | ||
| RIG-I activation inhibits ebolavirus replication | Q39821574 | ||
| A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus | Q40508331 | ||
| Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1 | Q24318342 | ||
| Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations | Q24620453 | ||
| Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus | Q27490714 | ||
| Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression | Q27646608 | ||
| Structure of the Ebola VP35 interferon inhibitory domain | Q27653329 | ||
| Mutations Abrogating VP35 Interaction with Double-Stranded RNA Render Ebola Virus Avirulent in Guinea Pigs | Q27658947 | ||
| Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35 | Q27659023 | ||
| MDA5 cooperatively forms dimers and ATP-sensitive filaments upon binding double-stranded RNA | Q27677137 | ||
| RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates | Q27861007 | ||
| Pathogen recognition by the innate immune system | Q29615592 | ||
| The Ebola virus VP35 protein is a suppressor of RNA silencing | Q33288729 | ||
| Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling | Q33558506 | ||
| Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems | Q33653597 | ||
| Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes | Q33785253 | ||
| Crystallization and preliminary X-ray analysis of Ebola VP35 interferon inhibitory domain mutant proteins | Q33902145 | ||
| Molecular mechanisms of viral inhibitors of RIG-I-like receptors | Q34253570 | ||
| Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence | Q34434866 | ||
| VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice | Q34509643 | ||
| Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling | Q34648134 | ||
| Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation | Q34648461 | ||
| Ebolavirus VP35 is a multifunctional virulence factor | Q34700463 | ||
| Marburg virus VP40 antagonizes interferon signaling in a species-specific manner. | Q35076858 | ||
| The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. | Q35105093 | ||
| Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. | Q35239001 | ||
| The Ebola virus VP35 protein functions as a type I IFN antagonist. | Q35422223 | ||
| The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. | Q35634367 | ||
| Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition | Q35641310 | ||
| Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus | Q36484103 | ||
| The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus | Q37157191 | ||
| Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain | Q37333731 | ||
| Evasion of interferon responses by Ebola and Marburg viruses | Q37582945 | ||
| Structural insights into RNA recognition and activation of RIG-I-like receptors | Q38007663 | ||
| P433 | issue | 50 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Marburg virus disease | Q167264 |
| Marburgvirus | Q15728844 | ||
| evasion of host immune response | Q1660157 | ||
| Marburg marburgvirus | Q6755280 | ||
| P304 | page(s) | 20661-6 | |
| P577 | publication date | 2012-12-11 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Structural basis for Marburg virus VP35-mediated immune evasion mechanisms | |
| P478 | volume | 109 |
| Q37504760 | A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever |
| Q40249528 | A novel mechanism of immune evasion mediated by Ebola virus soluble glycoprotein. |
| Q38218817 | An evolving arsenal: viral RNA detection by RIG-I-like receptors |
| Q21131118 | Animal models for Ebola and Marburg virus infections |
| Q21089589 | Characterization of uncultivable bat influenza virus using a replicative synthetic virus |
| Q59356029 | Conservation of Structure and Immune Antagonist Functions of Filoviral VP35 Homologs Present in Microbat Genomes |
| Q37560760 | Crystal Structure of the Marburg Virus VP35 Oligomerization Domain |
| Q27680060 | Development of RNA Aptamers Targeting Ebola Virus VP35 |
| Q36619514 | Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins |
| Q38419101 | Early IFN type I response: Learning from microbial evasion strategies |
| Q36449434 | Ebola virus disease. |
| Q27678917 | Ebolavirus VP35 Coats the Backbone of Double-Stranded RNA for Interferon Antagonism |
| Q39932766 | Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection |
| Q28550455 | Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea |
| Q42231570 | Exploring the mechanism how Marburg virus VP35 recognizes and binds dsRNA by molecular dynamics simulations and free energy calculations |
| Q58597801 | Extracellular RNA Sensing by Pattern Recognition Receptors |
| Q40132236 | Filovirus Strategies to Escape Antiviral Responses |
| Q40088356 | Filovirus Structural Biology: The Molecules in the Machine |
| Q38599899 | Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus |
| Q90341141 | Global phosphoproteomic analysis of Ebola virions reveals a novel role for VP35 phosphorylation-dependent regulation of genome transcription |
| Q24336169 | Hepatitis B virus core protein interacts with CD59 to promote complement-mediated liver inflammation during chronic hepatitis B virus infection |
| Q39092892 | Host and Viral Modulation of RIG-I-Mediated Antiviral Immunity |
| Q41673090 | Immunological Control of Viral Infections in Bats and the Emergence of Viruses Highly Pathogenic to Humans |
| Q36122433 | Immunological features underlying viral hemorrhagic fevers |
| Q27681581 | In Silico Derived Small Molecules Bind the Filovirus VP35 Protein and Inhibit Its Polymerase Cofactor Activity |
| Q36136841 | In silico and in vitro methods to identify ebola virus VP35-dsRNA inhibitors |
| Q38859305 | In silico study of VP35 inhibitors: from computational alanine scanning to essential dynamics |
| Q39021610 | Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. |
| Q35582244 | Innate immune evasion by filoviruses |
| Q38845221 | Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells. |
| Q27015752 | Marburg Virus Reverse Genetics Systems |
| Q59353567 | Marburg Virus Viral Protein 35 Inhibits Protein Kinase R Activation in a Cell Type-Specific Manner |
| Q64359278 | Marburg virus RNA synthesis is inhibited by a synthetic anti-VP35 antibody |
| Q38185897 | Mechanisms underlying the inhibition of interferon signaling by viruses |
| Q34536269 | Molecular Mechanisms of Innate Immune Inhibition by Non-Segmented Negative-Sense RNA Viruses |
| Q24310145 | Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome |
| Q38785678 | Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system |
| Q38237638 | Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5 |
| Q55435928 | RIG-I Detects Kaposi's Sarcoma-Associated Herpesvirus Transcripts in a RNA Polymerase III-Independent Manner. |
| Q28081618 | RIG-I in RNA virus recognition |
| Q38217394 | RIG-I-like receptors and negative-strand RNA viruses: RLRly bird catches some worms |
| Q64051850 | Recent advances in marburgvirus research |
| Q38926381 | Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses |
| Q38152910 | Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit. |
| Q30491838 | Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 peptide in Marburg virus |
| Q92702245 | The Innate Antiviral Response in Animals: An Evolutionary Perspective from Flagellates to Humans |
| Q36978855 | The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains |
| Q38235888 | The role of the IKK complex in viral infections |
| Q38726198 | VP24-Karyopherin Alpha Binding Affinities Differ between Ebolavirus Species, Influencing Interferon Inhibition and VP24 Stability. |
| Q28392078 | Viral evasion of intracellular DNA and RNA sensing |
| Q64119743 | Virus and host interactions critical for filoviral RNA synthesis as therapeutic targets |
| Q37568730 | When your cap matters: structural insights into self vs non-self recognition of 5' RNA by immunomodulatory host proteins |
Search more.